Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 55, 37-44
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 26 references indexed in Scilit:
- A prospective study of mastectomy patients with and without delayed breast reconstruction: Long‐term psychosocial functioning in the breast cancer survivorship periodJournal of Surgical Oncology, 2014
- Oncoplastic breast conservation surgery: The new paradigmJournal of Surgical Oncology, 2014
- A Classification System for Partial and Complete DIEP Flap Necrosis Based on a Review of 17,096 DIEP Flaps in 693 Articles Including Analysis of 152 Total Flap FailuresPlastic and Reconstructive Surgery, 2013
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsThe Lancet Oncology, 2013
- Oncoplastic and reconstructive surgery of the breastThe Breast, 2013
- Patient-Reported Satisfaction and Health-Related Quality of Life following Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- Fibrotic Changes after Postmastectomy Radiotherapy and Reconstructive Surgery in Breast CancerStrahlentherapie und Onkologie, 2010
- Hypofractionated breast radiotherapy: Financial and economic consequencesThe Breast, 2010
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerNew England Journal of Medicine, 2010
- Use of Breast Reconstruction After Mastectomy Following the Women's Health and Cancer Rights ActJAMA, 2006